KRKA, d.d., Novo mesto, Slovenia (batch control); KRKA, d.d., Novo mesto (secondary packaging, quality control and batch release)

The drug is used to treat symptoms of moderate to severe benign prostatic hyperplasia. It also helps reduce the risk of acute urinary retention and the need for surgical intervention.

Dosage form: capsules, soft gelatin

ATC: G04CB02